J. Morizet

发表

Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

G. Vassal, P. Couvreur, I. Brigger, 2002, Journal of Pharmacology and Experimental Therapeutics.

Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.

G. Vassal, P. Couvreur, M. Appel, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.

M. Mathieu, J. Morizet, N. Albin, 1993, Cancer research.

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

P. Opolon, B. Geoerger, G. Vassal, 2003, British Journal of Cancer.

Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.

P. Beaune, I. de Waziers, F. Janot, 1992, Cancer research.

Liquid chromatography-tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liver.

A. Paci, G. Vassal, J. Morizet, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma

P. Opolon, B. Geoerger, G. Vassal, 2005, The journal of gene medicine.

Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan

P. Opolon, B. Geoerger, M. Regairaz, 2006, Oncogene.

Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy.

F. Janot, V. Ribrag, J. Morizet, 1995, Leukemia & lymphoma.

Enhanced in vitro cytotoxicity of 1,3-bis-(2-chloroethyl)-1-nitrosourea or buthionine sulfoximine combined with a reactive oxygen-generating enzyme immunotoxin.

J. Morizet, H. Ito, V. Rousseau, 1990, Cancer letters.

Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38

S. Koscielny, M. Bissery, J. Morizet, 2004, Cancer Chemotherapy and Pharmacology.

Potent therapeutic activity of irinotecan (CPT‐11) and its schedule dependency in medulloblastoma xenografts in nude mice

C. Sainte-Rose, G. Vassal, M. Bissery, 1997, International journal of cancer.

Oncolytic Activity of the E 1 B-55 kDa-deleted Adenovirus ONYX-015 Is Independent of Cellular p 53 Status in Human Malignant Glioma Xenografts 1

P. Opolon, B. Geoerger, G. Vassal, 2002 .

The distribution of the CDW52 molecule on blood cells and characterization of its involvement in T cell activation.

A. Bernard, L. Coulombel, J. Morizet, 1992, Transplantation.

Preclinical development of camptothecin derivatives and clinical trials in pediatric oncology.

G. Vassal, E. Lucchi, C. Cappelli, 1998, Biochimie.

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

G. Vassal, J. Morizet, M. Terrier-Lacombe, 1999, British Journal of Cancer.

Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.

P. Opolon, B. Geoerger, G. Vassal, 2002, Cancer research.

In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations.

G. Vassal, A. Larsen, J. Morizet, 2004, Cancer research.

High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts

P. Opolon, M. Perricaudet, G. Vassal, 2003, Cancer Gene Therapy.

In-vivo effect of the combination of tnf and adriamycin against a human breast cell-line expressing the mdr-phenotype.

Z. Cai, S. Chouaib, J. Morizet, 1995, International journal of oncology.

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

G. Vassal, M. Bissery, J. Morizet, 1996, British Journal of Cancer.

Oncolytic Activity of p53-Expressing Conditionally Replicative Adenovirus AdΔ24-p53 against Human Malignant Glioma

G. Giaccone, P. Opolon, W. Vandertop, 2004, Cancer Research.

DNA-topoisomerase I, a new target for the treatment of neuroblastoma.

G. Vassal, C. Cappelli, J. Morizet, 1997, European journal of cancer.

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

P. Opolon, J. Schellens, G. Vassal, 2004, British Journal of Cancer.

Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.

G. Vassal, A. Watson, J. Morizet, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

T cell depletion of human bone marrow using an oxidase-peroxidase enzyme immunotoxin.

L. Coulombel, J. Morizet, H. Ito, 1990, Bone marrow transplantation.

An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097.

A. Bernard, L. Coulombel, J. Morizet, 1989, Bone marrow transplantation.

Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.

J. Morizet, N. Albin, L. Massaad, 1993, Cancer research.

Tumorigenicity of cerebellar primitive neuro‐ectodermal tumors in athymic mice correlates with poor prognosis in children

C. Sainte-Rose, G. Vassal, G. Riou, 1996, International journal of cancer.

Induction of Glutathione Synthesis Explains Pharmacodynamics of High-Dose Busulfan in Mice and Highlights Putative Mechanisms of Drug Interaction

P. Opolon, E. Connault, A. Paci, 2007, Drug Metabolism and Disposition.

EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts

P. Opolon, B. Geoerger, G. Vassal, 2008, International journal of cancer.

Test dose-guided administration of cisplatin in an anephric patient: a case report.

J. Droz, V. Ribrag, J. Morizet, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts

Jacques Grill, Gilles Vassal, C. Sainte-Rose, 2003, Cancer Chemotherapy and Pharmacology.

Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complement.

A. Bernard, P. Hervé, J. Morizet, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.